Literature DB >> 6194195

Clinical and immunologic aspects of allergen-specific immunotherapy in patients with seasonal allergic rhinitis and/or allergic asthma.

R E Rocklin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194195     DOI: 10.1016/0091-6749(83)90492-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  7 in total

1.  Immunologic histamine release from isolated human basophils during specific immunotherapy.

Authors:  S Chyrek-Borowska; B Kuczewska; A Rogalewska; J Hofman
Journal:  Agents Actions       Date:  1986-04

2.  Lymphocyte-mediated regulation of platelet activation during desensitization in patients with hymenoptera venom hypersensitivity.

Authors:  E Ledru; J Pestel; A Tsicopoulos; M Joseph; B Wallaert; A B Tonnel; A Capron
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

Review 3.  Standardized extracts modified allergens--allergoids.

Authors:  H J Maasch; D G Marsh
Journal:  Clin Rev Allergy       Date:  1987-02

Review 4.  Immunological response to immunotherapy for immediate hypersensitivity: clinical relevance.

Authors:  R Tamir; A I Pick
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

5.  Venom immunotherapy modulates interleukin-4 and interferon-gamma messenger RNA expression of peripheral T lymphocytes.

Authors:  H Akoum; A Tsicopoulos; H Vorng; B Wallaert; J P Dessaint; M Joseph; Q Hamid; A B Tonnel
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

6.  Recombinant pollen allergens from Dactylis glomerata: preliminary evidence that human IgE cross-reactivity between Dac g II and Lol p I/II is increased following grass pollen immunotherapy.

Authors:  A M Roberts; R Van Ree; S M Cardy; L J Bevan; M R Walker
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

Review 7.  Guidelines for the use of allergen immunotherapy. Canadian Society of Allergy and Clinical Immunology.

Authors: 
Journal:  CMAJ       Date:  1995-05-01       Impact factor: 8.262

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.